Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancerKIM, T. W; KANG, Y. K; AHN, J. H et al.Annals of oncology. 2002, Vol 13, Num 12, pp 1893-1898, issn 0923-7534, 6 p.Article

Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumoursRYU, M. H; KANG, Y. K; LEE, J. L et al.Histopathology. 2007, Vol 51, Num 3, pp 379-389, issn 0309-0167, 11 p.Article

Large Metastatic Lymph Node Size, Especially More Than 2 cm : Independent Predictor of Poor Prognosis in Node-Positive Gastric CarcinomaCHEONG; OH, S. T; KIM, B. S et al.World journal of surgery. 2008, Vol 32, Num 2, pp 262-266, issn 0364-2313, 5 p.Article

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancerKANG, H. J; CHANG, H. M; KIM, T. W et al.British journal of cancer. 2008, Vol 98, Num 2, pp 316-322, issn 0007-0920, 7 p.Article

Phase ii study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapyKANG, H. J; CHANG, H. M; KIM, T. W et al.British journal of cancer. 2005, Vol 92, Num 2, pp 246-251, issn 0007-0920, 6 p.Article

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)KANG, Y.-K; CHANG, H.-M; PARK, Y. S et al.British journal of cancer. 2013, Vol 108, Num 6, pp 1245-1251, issn 0007-0920, 7 p.Article

Usefulness of CT in patients with intestinal obstruction who have undergone abdominal surgery for malignancyHA, H. K; SHIN, B. S; AUH, Y. H et al.American journal of roentgenology (1976). 1998, Vol 171, Num 6, pp 1587-1593, issn 0361-803XConference Paper